Trial
NCT06215755
A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Verge Genomics
Collaborators
—
Condition
Amyotrophic Lateral Sclerosis
Intervention
VRG50635
Why stopped
Study terminated by Sponsor due to lack of risk-benefit data.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-15